Mississippi Delta Health Collaborative

Published Date
April 18th, 2024
Close Date
June 17th, 2024
Total Funding
Award Ceiling
Award Floor
Expected No. Awards
Opportunity No.


Centers for Disease Control - NCCDPHP (HHS-CDC-NCCDPHP)

Eligible Applicants


Funding Category


Funding Instrument

Cooperative Agreement

Opportunity Category


Cost Sharing or Matching Requirement



The Centers for Disease Control - NCCDPHP is offering a cooperative agreement grant opportunity titled "Mississippi Delta Health Collaborative". This grant aims to address the poor health and healthcare outcomes in the culturally rich Mississippi Delta region, particularly in relation to cardiovascular disease (CVD). The region's residents face challenges in accessing preventive services and care, and experience higher rates of CVD compared to the national average. The grant seeks to implement evidence-based and practice-based interventions that focus on health systems, team-based care, and linkages to community resources and clinical services. The Mississippi Department of Health / Mississippi Delta Health Collaborative (MDHC) is the sole eligible applicant for this funding opportunity. The grant has an award ceiling and floor of $3,150,000, with an estimated total program funding of $15,750,000. The deadline for electronically submitted applications is June 17, 2024, 11:59 pm ET. For more information, contact Rebekah Buckley at MSDelta24-0059@cdc.gov.


The Mississippi Delta is a historically and culturally rich region of the United States. The architecture, French, Spanish, British, and German, is as diverse as the people whose origins are European, Native American, Spanish, African, and more. But for all its cultural wealth, there is a poverty of health and healthcare in the region. Residents of the 18-county region contend with persistent poor health outcomes compounded by challenges to attaining preventive services and care, poor quality of care, and stagnant opportunity structures, particularly as it relates to cardiovascular disease (CVD).Roughly 1 in 10 (9.9% ≈ 28.6 million) adults in the US have at least 1 type of CVD, including coronary heart disease, heart failure, or stroke. This number excludes hypertension, a risk factor for and cause of CVD but not a type of CVD. However, hypertension or high blood pressure is a critical risk factor for stroke. An estimated 120 million American adults (48.1%) have it, most (3 in 4) don’t have it controlled, and 1 in 5 adults is unaware they have hypertension.In 2012 CVD, particularly heart disease, was the leading cause of death in the Delta (244.4 deaths per 100,000). The region’s residents experience age-adjusted death rates due to heart disease, stroke, and other CVDs that are considerably higher than national rates and the rest of Mississippi. According to the 2018 Cardiovascular Health Examination Survey (CHES) in the Mississippi Delta, the adjusted overall prevalence of hypertension among adults in the region 18 and older was 42.8%.The persistence of these outcomes in the Delta is attributable to modifiable CVD conditions and risk factors, such as high blood pressure, high cholesterol, coronary heart disease, COPD, chronic kidney disease, diabetes, and stroke. To sufficiently address these conditions, interventions must include evidence-based and practice-based approaches that are innovative and tailored to the unique challenges and strengths of the 18-county MS Delta Region. These interventions are needed in strategies that are focused on health systems, team-based care, and linkages to community resources and clinical services that address the social conditions that contribute to the prevalence of CVD in the MS Delta Region. This cooperative agreement builds from lessons learned from previous iterations. It focuses on policy, systems, and environmental changes that impact clinical and community settings and lifestyle changes that reduce uncontrolled blood pressure and CVD within the MS Delta Region.

Contact Information

Opportunity Lifecycle